{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:02:19Z","timestamp":1771297339893,"version":"3.50.1"},"reference-count":16,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T00:00:00Z","timestamp":1205884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The human beta defensins (hBDs) 2 and 3 contribute to the inducible antimicrobial peptides in human skin. Besides an important role in fighting bacteria, they may also exert antiviral function. Verrucae vulgares and condylomata acuminata are typical cutanous viral diseases caused by different subtypes of the human papillomavirus. Their tendency for spontaneous regression could be caused by antiviral proteins like defensins. In a retoperspective study, we investigated lesions of verrucae vulgares and condylomata acuminata for the presence of hBD\u20102 and hBD\u20103 by immunohistochemistry. All of the specimens of verrucae vulgares (<jats:italic>n<\/jats:italic>\u00a0=\u00a020) were positive for hBD\u20102 and hBD\u20103. The specimens of condylomata acuminata (<jats:italic>n<\/jats:italic>\u00a0=\u00a015) exhibited expression for hBD\u20102 and hBD\u20103, with the exception of three and two samples, respectively. The expression levels in condyloma acuminata were lower for both defensins compared with verrucae vulgares. Normal skin tissue exhibited no staining of both hBD\u20102 and hBD\u20103 with the exception of two cases. Taken together, this is the first report of an increased expression of the hBD\u20102 and hBD\u20103 in cutaneous papillomavirus infections.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2008.02675.x","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T18:45:50Z","timestamp":1205952350000},"page":"1050-1054","source":"Crossref","is-referenced-by-count":22,"title":["Expression of human beta\u2010defensin\u20102 and \u20103 in verrucae vulgares and condylomata acuminata"],"prefix":"10.1111","volume":"22","author":[{"given":"U","family":"Meyer\u2010Hoffert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u2010M","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Gl\u00e4ser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,8,18]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-005-5364-0"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.22.6.4023"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.11.5583"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/35106587"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01520"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1860"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2005.00295.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.23234.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8778"},{"key":"e_1_2_6_11_2","unstructured":"PimD CollinsM BanksL.Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 1992:7:27\u201332."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.20.11152-11160.2004"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200311070-00001"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-8244(03)00106-8"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.7.4637"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-3-75"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0508033103"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2008.02675.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2008.02675.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:33:20Z","timestamp":1697326400000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2008.02675.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,18]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1468-3083.2008.02675.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2008.02675.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,18]]}}}